The global surgical sphincteroplasty market is witnessing a significant surge, according to the latest report by Future Market Insight. The market is projected to reach USD 1.6 billion by the end of 2022. Over the next decade, it is forecasted to grow at a CAGR of 7.4%, reaching a remarkable valuation of USD 3.2 billion by 2032. This growth trajectory represents a notable increase from the historical CAGR of 6.1%.
Anal incontinence (AI) is a prevalent chronic condition affecting approximately 33% of the global population, as reported by the National Institute of Diabetes and Digestive and Kidney Diseases. Among women in the general population, the incidence is around 15%, with nursing home residents experiencing a much higher rate of approximately 50%. Factors such as pelvic surgery, age, recurrent diarrhea, obesity, diabetes, and stroke further elevate the risk of AI.
Request A Sample Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14803
Sphincteroplasty, the most common surgical intervention for moderate to severe AI cases unresponsive to conservative treatments, has emerged as a crucial solution. Non-surgical sphincteroplasty, particularly, has witnessed a rapid surge and is anticipated to grow at a CAGR of 7.2% during the forecast period, outpacing the historical growth rate.
“The increased prevalence of anal incontinence, coupled with advancements in sphincteroplasty procedures and the rising frequency of obstetric injuries post-childbirth, are key drivers propelling the global surgical sphincteroplasty market,” said a Future Market Insight.
Non-surgical interventions, including sacral nerve stimulation and vaginal balloon implants, are gaining traction, especially among the elderly population. These treatments offer a promising avenue for restoring anal sphincter control post-delivery and have shown positive outcomes in patients with end-stage AI and those unresponsive to conventional therapies.
The global surgical sphincteroplasty market is poised for substantial growth, presenting significant opportunities for stakeholders across the healthcare industry.
Key Takeaways:
- In 2021, the Surgical Sphincteroplasty Market reached a valuation of USD 1.5 billion, projected to rise to USD 1.6 billion by the close of 2022. Over the forecast period of 2022-2032, the Global Market for Surgical Sphincteroplasty is anticipated to present an absolute dollar opportunity of USD 1.6 billion.
- From 2017 to 2021, the Surgical Sphincteroplasty market displayed growth at a CAGR of 6.1%. Expectantly, this growth trajectory is set to accelerate, with the market poised to expand at a CAGR of 7.4% during 2022-2032, reaching a valuation of USD 3.2 billion by the end of 2032.
- According to the report from Future Market Insight, the Global Surgical Sphincteroplasty market is forecasted to double between 2022 and 2032. Within this growth landscape, the Non-Surgical segment is projected to assume dominance, expected to grow at a CAGR of 7.2% during the forecast period, surpassing the historical CAGR of 6.1%.
- Furthermore, North America is anticipated to emerge as the primary force driving the Global Market for Surgical Sphincteroplasty, with a projected CAGR of 7.2% during the forecast period.
Request Customization of the Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14803
Key factors driving the growth of the global surgical sphincteroplasty market:
- Increased Demand for Continence Solutions: Sphincteroplasty offers a viable surgical option compared to other treatments for incontinence. Its relative ease of use for surgeons and positive success rates are likely to boost its adoption in healthcare.
- Rising Prevalence of Anal Incontinence (AI): Several medical conditions are increasing at a concerning rate, including adult incontinence and obesity. These conditions can significantly elevate the risk of anal incontinence, potentially impacting up to 90% of sufferers. This rise in AI translates to a greater need for surgical solutions like sphincteroplasty.
- Advancements in Anal Incontinence Treatment: The development of innovative techniques for treating AI is propelling the market forward. These advancements offer hope for improved patient outcomes and potentially wider applicability of sphincteroplasty procedures.
- Growing Body of Clinical Research: The expanding number of clinical studies strengthens the understanding and efficacy of sphincteroplasty. This ongoing research plays a crucial role in establishing sphincteroplasty as a dependable treatment option.
Overall, the increasing prevalence of anal incontinence, growing acceptance of sphincteroplasty among surgeons, and ongoing advancements in treatment methods are all significant factors driving the global surgical sphincteroplasty market.
Competitive Analysis:
Major players in the Surgical Sphincteroplasty Market are ramping up their investment in research and development to pioneer cutting-edge solutions. Moreover, factors such as government backing, technological strides, regulatory endorsements, mergers and acquisitions, and diversification of product portfolios have all bolstered the competitive landscape.
Prominent contenders in the Surgical Sphincteroplasty Market include Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., Johnson & Johnson, and others.
- In December 2021, Baxter International Inc. finalized the purchase of Hillrom for a sum of USD 12.5 billion, furthering its ambition to revolutionize healthcare by extending services from hospitals to homes.
- Meanwhile, in November 2021, Walgreens Boots Alliance secured a 30% ownership in McKesson’s German GEHE-Alliance Healthcare Joint Venture, marking the initial step toward assuming full ownership of the venture. Ultimately, Walgreens Boots Alliance aims to attain 100% control, reclaiming ownership from McKesson.
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/14803
Market Segments Covered In Surgical Sphincteroplasty Market Analysis:
By Type:
- Surgical
- Direct apposition sphincteroplasty
- Overlapping sphincteroplasty
- Non-Surgical
- Sacral nerve stimulation
- Vaginal balloon inserts
- Other Non-Surgical
By Region type:
- North America
- Latin America
- Europe
- APAC
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
